Different CK19 expression levels have been described for other malignancies such as colorectal (94.1%) [36], gastric (98.6%) [39], gynecological (98%) [43], lung (96%) [48], HNSCC (91.1%) [49] or PCa (100%) [23]. This evidence concerns the gene KRT19 and head and neck squamous cell carcinoma.